Research use only≥Research Peptides
CJC-1295 Research Peptide
Research use only · Not for human consumption
$75.005 mg / vial
GHRH analogue reference material prepared for in vitro analytical use.
1
Independently verified
≥ 99% (HPLC)
Reverse-phase HPLC · Mass-spec confirmed
Lot
AP-2401
Released
2026
Endotoxin
< 0.5 EU/mg
Residual
< 0.5%
Certificate of Analysis
Lot-matched COA available on request.
Third-party tested
Released against independent HPLC.
ISO-grade reagents
From audited synthesis partners.
Cold-chain dispatch
Temperature-controlled Australia-wide.
Request Certificate of Analysis · Lot AP-2401
Description+
CJC-1295 is supplied as a sterile lyophilised powder intended for laboratory research. Material is suitable for HPLC reference, receptor binding assays, and other qualified in vitro applications.
Storage+
Sealed vials: 2–8 °C. Reconstituted solutions: -20 °C, protected from freeze-thaw cycling.
Specification+
- Purity
- ≥ 99% (HPLC)
- Size
- 5 mg / vial
- Form
- Lyophilised powder
Compliance+
Disclaimer: All products supplied by Australia Wide Peptides are intended strictly for laboratory research purposes only. They are not approved for human or animal consumption, nor for any therapeutic, diagnostic, or medicinal use. The information provided on this website has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory authority. These compounds are not designed to diagnose, treat, cure, or prevent any disease or medical condition. Purchase is restricted to qualified professionals, researchers, or research institutions within Australia and internationally. By placing an order, you confirm that you understand and agree to these terms.
Related
You may also be researching
Compliance notice
Disclaimer: All products supplied by Australia Wide Peptides are intended strictly for laboratory research purposes only. They are not approved for human or animal consumption, nor for any therapeutic, diagnostic, or medicinal use. The information provided on this website has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory authority. These compounds are not designed to diagnose, treat, cure, or prevent any disease or medical condition. Purchase is restricted to qualified professionals, researchers, or research institutions within Australia and internationally. By placing an order, you confirm that you understand and agree to these terms.